The Human Gut Microbiome: From Association to Modulation

Cell

Volumn 172, Issue 6, 2018, Pages 1198-1215

  Schmidt, Thomas S B ^a   Raes, Jeroen ^b,c   Bork, Peer ^a,d,e  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

BODY MASS; CLOSTRIDIUM DIFFICILE INFECTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; GASTROINTESTINAL TRACT; GENETIC ASSOCIATION STUDY; GENOME-WIDE ASSOCIATION STUDY; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; INTESTINE LAVAGE; LIFESTYLE; METAGENOME WIDE ASSOCIATION STUDY; MICROBIAL DIVERSITY; MICROBIAL METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECIES COMPOSITION; TAXONOMY; DISEASES; HEALTH STATUS; METABOLISM; METABOLOMICS; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; RESEARCH; TRENDS;

DISEASE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HEALTH STATUS; HOST MICROBIAL INTERACTIONS; HUMANS; METABOLOMICS; RESEARCH;

EID: 85043338987     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.02.044     Document Type: Review

References (213)

1. Abu-Ali, G.S., Mehta, R.S., Lloyd-Price, J., Mallick, H., Branck, T., Ivey, K.L., Drew, D.A., DuLong, C., Rimm, E., Izard, J., et al. Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nat. Microbiol., 106, 2018, 1.
2. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., Fernandes, G.R., Tap, J., Bruls, T., Batto, J.-M., et al., MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
3. Asnicar, F., Manara, S., Zolfo, M., Truong, D.T., Scholz, M., Armanini, F., Ferretti, P., Gorfer, V., Pedrotti, A., Tett, A., Segata, N., Studying vertical microbiome transmission from mothers to infants by strain-level metagenomic profiling. mSystems, 2, 2017 e00164–e16.
4. Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17 (2015), 690–703.
5. Bahr, S.M., Tyler, B.C., Wooldridge, N., Butcher, B.D., Burns, T.L., Teesch, L.M., Oltman, C.L., Azcarate-Peril, M.A., Kirby, J.R., Calarge, C.A., Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl. Psychiatry, 5, 2015, e652.
6. Barton, W., Penney, N.C., Cronin, O., Garcia-Perez, I., Molloy, M.G., Holmes, E., Shanahan, F., Cotter, P.D., O'Sullivan, O., The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut, 313, 2017, 627.
7. Becattini, S., Taur, Y., Pamer, E.G., Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol. Med. 22 (2016), 458–478.
8. Belkaid, Y., Hand, T.W., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.
9. Bender, E.A., Case, T.J., Gilpin, M.E., Perturbation experiments in community ecology: theory and practice. Ecology 65 (1984), 1–13.
10. Beserra, B.T.S., Fernandes, R., do Rosario, V.A., Mocellin, M.C., Kuntz, M.G.F., Trindade, E.B.S.M., A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin. Nutr. 34 (2015), 845–858.
11. Biedermann, L., Zeitz, J., Mwinyi, J., Sutter-Minder, E., Rehman, A., Ott, S.J., Steurer-Stey, C., Frei, A., Frei, P., Scharl, M., et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS ONE, 8, 2013, e59260.
12. Bonder, M.J., Kurilshikov, A., Tigchelaar, E.F., Mujagic, Z., Imhann, F., Vila, A.V., Deelen, P., Vatanen, T., Schirmer, M., Smeekens, S.P., et al. The effect of host genetics on the gut microbiome. Nat. Genet. 48 (2016), 1407–1412.
13. Bucci, V., Xavier, J.B., Towards predictive models of the human gut microbiome. J. Mol. Biol. 426 (2014), 3907–3916.
14. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
15. Carabotti, M., Scirocco, A., Maselli, M.A., Severi, C., The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 28 (2015), 203–209.
16. Chu, D.M., Ma, J., Prince, A.L., Antony, K.M., Seferovic, M.D., Aagaard, K.M., Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 23 (2017), 314–326.
17. Clarke, S.F., Murphy, E.F., O'Sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I.B., Wood-Martin, R., et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63 (2014), 1913–1920.
18. Conceição-Neto, N., Deboutte, W., Dierckx, T., Machiels, K., Wang, J., Yinda, K.C., Maes, P., Van Ranst, M., Joossens, M., Raes, J., et al. Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC. Gut, 315, 2017, 281.
19. Costea, P.I., Coelho, L.P., Sunagawa, S., Munch, R., Huerta-Cepas, J., Forslund, K., Hildebrand, F., Kushugulova, A., Zeller, G., Bork, P., Subspecies in the global human gut microbiome. Mol. Syst. Biol., 13, 2017, 960.
20. Costea, P.I., Zeller, G., Sunagawa, S., Pelletier, E., Alberti, A., Levenez, F., Tramontano, M., Driessen, M., Hercog, R., Jung, F.-E., et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35 (2017), 1069–1076.
21. Costea, P.I., Munch, R., Coelho, L.P., Paoli, L., Sunagawa, S., Bork, P., metaSNV: A tool for metagenomic strain level analysis. PLoS ONE, 12, 2017, e0182392.
22. Costea, P.I., Hildebrand, F., Manimozhiyan, A., Bäckhed, F., Blaser, M.J., Bushman, F.D., de Vos, W.M., Ehrlich, S.D., Fraser, C.M., Hattori, M., et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3 (2018), 8–16.
23. Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., et al., ANR MicroObes consortium. Dietary intervention impact on gut microbial gene richness. Nature 500 (2013), 585–588.
24. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
25. de Groot, P.F., Frissen, M.N., de Clercq, N.C., Nieuwdorp, M., Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes 8 (2017), 253–267.
26. Dethlefsen, L., Relman, D.A., Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4554–4561.
27. Dethlefsen, L., Huse, S., Sogin, M.L., Relman, D.A., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol., 6, 2008, e280.
28. Ding, T., Schloss, P.D., Dynamics and associations of microbial community types across the human body. Nature 509 (2014), 357–360.
29. Dodd, D., Spitzer, M.H., Van Treuren, W., Merrill, B.D., Hryckowian, A.J., Higginbottom, S.K., Le, A., Cowan, T.M., Nolan, G.P., Fischbach, M.A., Sonnenburg, J.L., A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551 (2017), 648–652.
30. Dubinkina, V.B., Tyakht, A.V., Odintsova, V.Y., Yarygin, K.S., Kovarsky, B.A., Pavlenko, A.V., Ischenko, D.S., Popenko, A.S., Alexeev, D.G., Taraskina, A.Y., et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome, 5, 2017, 141.
31. Duvallet, C., Gibbons, S.M., Gurry, T., Irizarry, R.A., Alm, E.J., Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat. Commun., 8, 2017, 1784.
32. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
33. Erickson, A.R., Cantarel, B.L., Lamendella, R., Darzi, Y., Mongodin, E.F., Pan, C., Shah, M., Halfvarson, J., Tysk, C., Henrissat, B., et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE, 7, 2012, e49138.
34. Faith, J.J., Guruge, J.L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A.L., Clemente, J.C., Knight, R., Heath, A.C., Leibel, R.L., et al. The long-term stability of the human gut microbiota. Science, 341, 2013, 1237439.
35. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M.J., Valles-Colomer, M., Vandeputte, D., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
36. Faust, K., Raes, J., Microbial interactions: from networks to models. Nat. Rev. Microbiol. 10 (2012), 538–550.
37. Faust, K., Lahti, L., Gonze, D., de Vos, W.M., Raes, J., Metagenomics meets time series analysis: unraveling microbial community dynamics. Curr. Opin. Microbiol. 25 (2015), 56–66.
38. Finucane, M.M., Sharpton, T.J., Laurent, T.J., Pollard, K.S., A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS ONE, 9, 2014, e84689.
39. Flint, H.J., Scott, K.P., Louis, P., Duncan, S.H., The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9 (2012), 577–589.
40. Flint, H.J., Duncan, S.H., Louis, P., The impact of nutrition on intestinal bacterial communities. Curr. Opin. Microbiol. 38 (2017), 59–65.
41. Flowers, S.A., Evans, S.J., Ward, K.M., McInnis, M.G., Ellingrod, V.L., Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy 37 (2017), 261–267.
42. Ford, A.C., Quigley, E.M.M., Lacy, B.E., Lembo, A.J., Saito, Y.A., Schiller, L.R., Soffer, E.E., Spiegel, B.M.R., Moayyedi, P., Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am. J. Gastroenterol., 109, 2014 1547–1561, quiz 1546, 1562.
43. Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Pedersen, H.K., et al., MetaHIT consortium. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
44. Franzosa, E.A., Hsu, T., Sirota-Madi, A., Shafquat, A., Abu-Ali, G., Morgan, X.C., Huttenhower, C., Sequencing and beyond: integrating molecular ‘omics’ for microbial community profiling. Nat. Rev. Microbiol. 13 (2015), 360–372.
45. Freedberg, D.E., Toussaint, N.C., Chen, S.P., Ratner, A.J., Whittier, S., Wang, T.C., Wang, H.H., Abrams, J.A., Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology 149 (2015), 883–885.
46. Friedman, J., Alm, E.J., Inferring correlation networks from genomic survey data. PLoS Comput. Biol., 8, 2012, e1002687.
47. Fuentes, S., van Nood, E., Tims, S., Heikamp-de Jong, I., ter Braak, C.J., Keller, J.J., Zoetendal, E.G., de Vos, W.M., Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 8 (2014), 1621–1633.
48. Fuentes, S., Rossen, N.G., van der Spek, M.J., Hartman, J.H., Huuskonen, L., Korpela, K., Salojärvi, J., Aalvink, S., de Vos, W.M., D'Haens, G.R., et al. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. ISME J. 11 (2017), 1877–1889.
49. Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., Panzer, A.R., LaMere, B., Rackaityte, E., Lukacs, N.W., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 22 (2016), 1187–1191.
50. Fukuyama, J., Rumker, L., Sankaran, K., Jeganathan, P., Dethlefsen, L., Relman, D.A., Holmes, S.P., Multidomain analyses of a longitudinal human microbiome intestinal cleanout perturbation experiment. PLoS Comput. Biol., 13, 2017, e1005706.
51. Gaci, N., Borrel, G., Tottey, W., O'Toole, P.W., Brugère, J.-F., Archaea and the human gut: new beginning of an old story. World J. Gastroenterol. 20 (2014), 16062–16078.
52. Galardini, M., Koumoutsi, A., Herrera-Dominguez, L., Cordero Varela, J.A., Telzerow, A., Wagih, O., Wartel, M., Clermont, O., Denamur, E., Typas, A., Beltrao, P., Phenotype inference in an Escherichia coli strain panel. eLife, 6, 2017, 68.
53. García-González, A.P., Ritter, A.D., Shrestha, S., Andersen, E.C., Yilmaz, L.S., Walhout, A.J.M., Bacterial metabolism affects the C. elegans response to cancer chemotherapeutics. Cell 169 (2017), 431–441.e8.
54. Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Scott, K., Stanton, C., Swanson, K.S., Cani, P.D., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 491–502.
55. Gilbert, J.A., Quinn, R.A., Debelius, J., Xu, Z.Z., Morton, J., Garg, N., Jansson, J.K., Dorrestein, P.C., Knight, R., Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535 (2016), 94–103.
56. Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J.T., et al. Human genetics shape the gut microbiome. Cell 159 (2014), 789–799.
57. Goodrich, J.K., Davenport, E.R., Beaumont, M., Jackson, M.A., Knight, R., Ober, C., Spector, T.D., Bell, J.T., Clark, A.G., Ley, R.E., Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19 (2016), 731–743.
58. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., Prieto, P.A., Vicente, D., Hoffman, K., Wei, S.C., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (2018), 97–103.
59. Haiser, H.J., Gootenberg, D.B., Chatman, K., Sirasani, G., Balskus, E.P., Turnbaugh, P.J., Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341 (2013), 295–298.
60. Hall, A.B., Tolonen, A.C., Xavier, R.J., Human genetic variation and the gut microbiome in disease. Nat. Rev. Genet. 18 (2017), 690–699.
61. Hang, J., Desai, V., Zavaljevski, N., Yang, Y., Lin, X., Satya, R.V., Martinez, L.J., Blaylock, J.M., Jarman, R.G., Thomas, S.J., Kuschner, R.A., 16S rRNA gene pyrosequencing of reference and clinical samples and investigation of the temperature stability of microbiome profiles. Microbiome, 2, 2014, 31.
62. Heintz-Buschart, A., Wilmes, P., Human gut microbiome: function matters. Trends Microbiol., 2017 Published online November 22, 2017. S0966-842X(17)30251-2.
63. Heintz-Buschart, A., May, P., Laczny, C.C., Lebrun, L.A., Bellora, C., Krishna, A., Wampach, L., Schneider, J.G., Hogan, A., de Beaufort, C., Wilmes, P., Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat. Microbiol., 2, 2016, 16180.
64. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 506–514.
65. Hoisington, A.J., Brenner, L.A., Kinney, K.A., Postolache, T.T., Lowry, C.A., The microbiome of the built environment and mental health. Microbiome, 3, 2015, 60.
66. Hooper, L.V., Littman, D.R., Macpherson, A.J., Interactions between the microbiota and the immune system. Science 336 (2012), 1268–1273.
67. Hugenholtz, F., de Vos, W.M., Mouse models for human intestinal microbiota research: a critical evaluation. Cell. Mol. Life Sci. 75 (2018), 149–160.
68. Hughes, E.R., Winter, M.G., Duerkop, B.A., Spiga, L., Furtado de Carvalho, T., Zhu, W., Gillis, C.C., Büttner, L., Smoot, M.P., Behrendt, C.L., et al. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis. Cell Host Microbe 21 (2017), 208–219.
69. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
70. Hurwitz, B.L., U'Ren, J.M., Youens-Clark, K., Computational prospecting the great viral unknown. FEMS Microbiol. Lett., 363, 2016, fnw077.
71. Imhann, F., Bonder, M.J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E.F., Jankipersadsing, S.A., Cenit, M.C., Harmsen, H.J.M., et al. Proton pump inhibitors affect the gut microbiome. Gut 65 (2016), 740–748.
72. Ioannidis, J.P.A., Implausible results in human nutrition research. BMJ, 347, 2013, f6698.
73. Jackson, M.A., Bell, J.T., Spector, T.D., Steves, C.J., A heritability-based comparison of methods used to cluster 16S rRNA gene sequences into operational taxonomic units. PeerJ, 4, 2016, e2341.
74. Jakobsson, H.E., Jernberg, C., Andersson, A.F., Sjölund-Karlsson, M., Jansson, J.K., Engstrand, L., Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE, 5, 2010, e9836.
75. Jalanka, J., Salonen, A., Salojärvi, J., Ritari, J., Immonen, O., Marciani, L., Gowland, P., Hoad, C., Garsed, K., Lam, C., et al. Effects of bowel cleansing on the intestinal microbiota. Gut 64 (2015), 1562–1568.
76. Jansen, R.C., Studying complex biological systems using multifactorial perturbation. Nat. Rev. Genet. 4 (2003), 145–151.
77. Jeffery, I.B., Lynch, D.B., O'Toole, P.W., Composition and temporal stability of the gut microbiota in older persons. ISME J. 10 (2016), 170–182.
78. Jernberg, C., Löfmark, S., Edlund, C., Jansson, J.K., Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1 (2007), 56–66.
79. Kaper, J.B., Nataro, J.P., Mobley, H.L.T., Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2 (2004), 123–140.
80. Kim, H.J., Huh, D., Hamilton, G., Ingber, D.E., Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12 (2012), 2165–2174.
81. Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., Angenent, L.T., Ley, R.E., Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4578–4585.
82. Kolmeder, C.A., de Vos, W.M., Metaproteomics of our microbiome - developing insight in function and activity in man and model systems. J. Proteomics 97 (2014), 3–16.
83. Kootte, R.S., Levin, E., Salojärvi, J., Smits, L.P., Hartstra, A.V., Udayappan, S.D., Hermes, G., Bouter, K.E., Koopen, A.M., Holst, J.J., et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 26 (2017), 611–619.
84. Korpela, K., Costea, P.I., Coelho, L.P., Kandels-Lewis, S., Willemsen, G., Boomsma, D.I., Segata, N., Bork, P., Selective maternal seeding and environment shape the human gut microbiome. Genome Res., 2018, 10.1101/gr.233940.117.
85. Koskella, B., Hall, L.J., Metcalf, C.J.E., The microbiome beyond the horizon of ecological and evolutionary theory. Nat. Ecol. Evol. 1 (2017), 1606–1615.
86. Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., Bäckhed, F., Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 22 (2015), 971–982.
87. Kristensen, N.B., Bryrup, T., Allin, K.H., Nielsen, T., Hansen, T.H., Pedersen, O., Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med., 8, 2016, 52.
88. Kumar, R., Yi, N., Zhi, D., Eipers, P., Goldsmith, K.T., Dixon, P., Crossman, D.K., Crowley, M.R., Lefkowitz, E.J., Rodriguez, J.M., Morrow, C.D., Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. NPJ Biofilms Microbiomes, 3, 2017, 12.
89. Kundu, P., Blacher, E., Elinav, E., Pettersson, S., Our gut microbiome: the evolving inner self. Cell 171 (2017), 1481–1493.
90. Kurilshikov, A., Wijmenga, C., Fu, J., Zhernakova, A., Host genetics and gut microbiome: challenges and perspectives. Trends Immunol. 38 (2017), 633–647.
91. La Rosa, P.S., Warner, B.B., Zhou, Y., Weinstock, G.M., Sodergren, E., Hall-Moore, C.M., Stevens, H.J., Bennett, W.E. Jr., Shaikh, N., Linneman, L.A., et al. Patterned progression of bacterial populations in the premature infant gut. Proc. Natl. Acad. Sci. USA 111 (2014), 12522–12527.
92. Langdon, A., Crook, N., Dantas, G., The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med., 8, 2016, 39.
93. Lax, S., Smith, D.P., Hampton-Marcell, J., Owens, S.M., Handley, K.M., Scott, N.M., Gibbons, S.M., Larsen, P., Shogan, B.D., Weiss, S., et al. Longitudinal analysis of microbial interaction between humans and the indoor environment. Science 345 (2014), 1048–1052.
94. Le Bastard, Q., Al-Ghalith, G.A., Grégoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., Montassier, E., Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment. Pharmacol. Ther. 47 (2018), 332–345.
95. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al., MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
96. Lee, S.T.M., Kahn, S.A., Delmont, T.O., Shaiber, A., Esen, Ö.C., Hubert, N.A., Morrison, H.G., Antonopoulos, D.A., Rubin, D.T., Eren, A.M., Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome, 5, 2017, 50.
97. Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., Arumugam, M., Kultima, J.R., Prifti, E., Nielsen, T., et al., MetaHIT Consortium. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32 (2014), 834–841.
98. Li, S.S., Zhu, A., Benes, V., Costea, P.I., Hercog, R., Hildebrand, F., Huerta-Cepas, J., Nieuwdorp, M., Salojärvi, J., Voigt, A.Y., et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589.
99. Lloyd-Price, J., Abu-Ali, G., Huttenhower, C., The healthy human microbiome. Genome Med., 8, 2016, 51.
100. Lloyd-Price, J., Mahurkar, A., Rahnavard, G., Crabtree, J., Orvis, J., Hall, A.B., Brady, A., Creasy, H.H., McCracken, C., Giglio, M.G., et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550 (2017), 61–66.
101. Lynch, S.V., Pedersen, O., The human intestinal microbiome in health and disease. N. Engl. J. Med. 375 (2016), 2369–2379.
102. Maier, L., Typas, A., Systematically investigating the impact of medication on the gut microbiome. Curr. Opin. Microbiol. 39 (2017), 128–135.
103. Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E.E., Brochado, A.R., Fernandez, K.C., Dose, H., Mori, H., et al. Extensive impact of non-antibiotic drugs on human gut microbiota. Nature, 2018, 10.1038/nature25979.
104. Mäkivuokko, H., Tiihonen, K., Tynkkynen, S., Paulin, L., Rautonen, N., The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br. J. Nutr. 103 (2010), 227–234.
105. Mallick, H., Ma, S., Franzosa, E.A., Vatanen, T., Morgan, X.C., Huttenhower, C., Experimental design and quantitative analysis of microbial community multiomics. Genome Biol., 18, 2017, 228.
106. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55 (2006), 205–211.
107. Martí, J.M., Martínez-Martínez, D., Rubio, T., Gracia, C., Peña, M., Latorre, A., Moya, A., P Garay, C., Health and disease imprinted in the time variability of the human microbiome. mSystems, 2, 2017 e00144–e16.
108. Marzorati, M., Vanhoecke, B., De Ryck, T., Sadaghian Sadabad, M., Pinheiro, I., Possemiers, S., Van den Abbeele, P., Derycke, L., Bracke, M., Pieters, J., et al. The HMI™ module: a new tool to study the Host-Microbiota Interaction in the human gastrointestinal tract in vitro. BMC Microbiol., 14, 2014, 133.
109. Matias Rodrigues, J.F., Schmidt, T.S.B., Tackmann, J., von Mering, C., MAPseq: highly efficient k-mer search with confidence estimates, for rRNA sequence analysis. Bioinformatics 33 (2017), 3808–3810.
110. Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J.J., Gajewski, T.F., The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359 (2018), 104–108.
111. Moss, E.L., Falconer, S.B., Tkachenko, E., Wang, M., Systrom, H., Mahabamunuge, J., Relman, D.A., Hohmann, E.L., Bhatt, A.S., Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients. PLoS ONE, 12, 2017, e0182585.
112. Muegge, B.D., Kuczynski, J., Knights, D., Clemente, J.C., González, A., Fontana, L., Henrissat, B., Knight, R., Gordon, J.I., Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332 (2011), 970–974.
113. Mukherjee, S., Seshadri, R., Varghese, N.J., Eloe-Fadrosh, E.A., Meier-Kolthoff, J.P., Göker, M., Coates, R.C., Hadjithomas, M., Pavlopoulos, G.A., Paez-Espino, D., et al. 1,003 reference genomes of bacterial and archaeal isolates expand coverage of the tree of life. Nat. Biotechnol. 35 (2017), 676–683.
114. Narula, N., Kassam, Z., Yuan, Y., Colombel, J.-F., Ponsioen, C., Reinisch, W., Moayyedi, P., Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis. Inflamm. Bowel Dis. 23 (2017), 1702–1709.
115. Nayfach, S., Rodriguez-Mueller, B., Garud, N., Pollard, K.S., An integrated metagenomics pipeline for strain profiling reveals novel patterns of bacterial transmission and biogeography. Genome Res. 26 (2016), 1612–1625.
116. Nelson, K.E., Weinstock, G.M., Highlander, S.K., Worley, K.C., Creasy, H.H., Wortman, J.R., Rusch, D.B., Mitreva, M., Sodergren, E., Chinwalla, A.T., et al., Human Microbiome Jumpstart Reference Strains Consortium. A catalog of reference genomes from the human microbiome. Science 328 (2010), 994–999.
117. Neville, B.A., Forster, S.C., Lawley, T.D., Commensal Koch's postulates: establishing causation in human microbiota research. Curr. Opin. Microbiol. 42 (2017), 47–52.
118. Nguyen, T.L.A., Vieira-Silva, S., Liston, A., Raes, J., How informative is the mouse for human gut microbiota research?. Dis. Model. Mech. 8 (2015), 1–16.
119. Noguera-Julian, M., Rocafort, M., Guillén, Y., Rivera, J., Casadellà, M., Nowak, P., Hildebrand, F., Zeller, G., Parera, M., Bellido, R., et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine 5 (2016), 135–146.
120. O'Toole, P.W., Jeffery, I.B., Gut microbiota and aging. Science 350 (2015), 1214–1215.
121. Obregon-Tito, A.J., Tito, R.Y., Metcalf, J., Sankaranarayanan, K., Clemente, J.C., Ursell, L.K., Zech Xu, Z., Van Treuren, W., Knight, R., Gaffney, P.M., et al. Subsistence strategies in traditional societies distinguish gut microbiomes. Nat. Commun., 6, 2015, 6505.
122. Odamaki, T., Kato, K., Sugahara, H., Hashikura, N., Takahashi, S., Xiao, J.-Z., Abe, F., Osawa, R., Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol., 16, 2016, 90.
123. Ogilvie, L.A., Jones, B.V., The human gut virome: a multifaceted majority. Front. Microbiol., 6, 2015, 918.
124. Ott, S.J., Musfeldt, M., Wenderoth, D.F., Hampe, J., Brant, O., Fölsch, U.R., Timmis, K.N., Schreiber, S., Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53 (2004), 685–693.
125. Parfrey, L.W., Walters, W.A., Knight, R., Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions. Front. Microbiol., 2, 2011, 153.
126. Pasolli, E., Truong, D.T., Malik, F., Waldron, L., Segata, N., Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput. Biol., 12, 2016, e1004977.
127. Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A.H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al., MetaHIT Consortium. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (2016), 376–381.
128. Petersen, L.M., Bautista, E.J., Nguyen, H., Hanson, B.M., Chen, L., Lek, S.H., Sodergren, E., Weinstock, G.M., Community characteristics of the gut microbiomes of competitive cyclists. Microbiome, 5, 2017, 98.
129. Phillips, B.L., Shine, R., Adapting to an invasive species: toxic cane toads induce morphological change in Australian snakes. Proc. Natl. Acad. Sci. USA 101 (2004), 17150–17155.
130. Props, R., Kerckhof, F.-M., Rubbens, P., De Vrieze, J., Hernandez Sanabria, E., Waegeman, W., Monsieurs, P., Hammes, F., Boon, N., Absolute quantification of microbial taxon abundances. ISME J. 11 (2017), 584–587.
131. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al., MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
132. Quince, C., Delmont, T.O., Raguideau, S., Alneberg, J., Darling, A.E., Collins, G., Eren, A.M., DESMAN: a new tool for de novo extraction of strains from metagenomes. Genome Biol., 18, 2017, 181.
133. Raes, J., Bork, P., Molecular eco-systems biology: towards an understanding of community function. Nat. Rev. Microbiol. 6 (2008), 693–699.
134. Raymond, F., Ouameur, A.A., Déraspe, M., Iqbal, N., Gingras, H., Dridi, B., Leprohon, P., Plante, P.-L., Giroux, R., Bérubé, È., et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J. 10 (2016), 707–720.
135. Rettedal, E.A., Gumpert, H., Sommer, M.O.A., Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nat. Commun., 5, 2014, 4714.
136. Roager, H.M., Licht, T.R., Poulsen, S.K., Larsen, T.M., Bahl, M.I., Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet. Appl. Environ. Microbiol. 80 (2014), 1142–1149.
137. Roager, H.M., Hansen, L.B.S., Bahl, M.I., Frandsen, H.L., Carvalho, V., Gøbel, R.J., Dalgaard, M.D., Plichta, D.R., Sparholt, M.H., Vestergaard, H., et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat. Microbiol., 1, 2016, 16093.
138. Rogers, M.A.M., Aronoff, D.M., The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clin. Microbiol. Infect. 22 (2016), 178.e1–178.e9.
139. Rothschild, D., Weissbrod, O., Barkan, E., Korem, T., Zeevi, D., Costea, P.I., Godneva, A., Kalka, I.N., Bar, N., Zmora, N., et al. Environmental factors dominate over host genetics in shaping human gut microbiota composition. Nature., 2018, 10.1038/nature25973.
140. Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M.P., et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science 359 (2018), 91–97.
141. Satinsky, B.M., Gifford, S.M., Crump, B.C., Moran, M.A., Use of internal standards for quantitative metatranscriptome and metagenome analysis. Methods Enzymol. 531 (2013), 237–250.
142. Scher, J.U., Sczesnak, A., Longman, R.S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E.G., Abramson, S.B., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife, 2, 2013, e01202.
143. Schirmer, M., Franzosa, E.A., Lloyd-Price, J., McIver, L.J., Schwager, R., Poon, T.W., Ananthakrishnan, A.N., Andrews, E., Barron, G., Lake, K., et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol., 7, 2018, 1.
144. Schloissnig, S., Arumugam, M., Sunagawa, S., Mitreva, M., Tap, J., Zhu, A., Waller, A., Mende, D.R., Kultima, J.R., Martin, J., et al. Genomic variation landscape of the human gut microbiome. Nature 493 (2013), 45–50.
145. Scholz, M., Ward, D.V., Pasolli, E., Tolio, T., Zolfo, M., Asnicar, F., Truong, D.T., Tett, A., Morrow, A.L., Segata, N., Strain-level microbial epidemiology and population genomics from shotgun metagenomics. Nat. Methods 13 (2016), 435–438.
146. Scott, T.A., Quintaneiro, L.M., Norvaisas, P., Lui, P.P., Wilson, M.P., Leung, K.-Y., Herrera-Dominguez, L., Sudiwala, S., Pessia, A., Clayton, P.T., et al. Host-microbe co-metabolism dictates cancer drug efficacy in C. elegans. Cell 169 (2017), 442–456.
147. Seekatz, A.M., Aas, J., Gessert, C.E., Rubin, T.A., Saman, D.M., Bakken, J.S., Young, V.B., Recovery of the gut microbiome following fecal microbiota transplantation. MBio, 5, 2014 e00893–e14.
148. Shade, A., Peter, H., Allison, S.D., Baho, D.L., Berga, M., Bürgmann, H., Huber, D.H., Langenheder, S., Lennon, J.T., Martiny, J.B.H., et al. Fundamentals of microbial community resistance and resilience. Front. Microbiol., 3, 2012, 417.
149. Shah, P., Fritz, J.V., Glaab, E., Desai, M.S., Greenhalgh, K., Frachet, A., Niegowska, M., Estes, M., Jäger, C., Seguin-Devaux, C., et al. A microfluidics-based in vitro model of the gastrointestinal human-microbe interface. Nat. Commun., 7, 2016, 11535.
150. Shoaie, S., Ghaffari, P., Kovatcheva-Datchary, P., Mardinoglu, A., Sen, P., Pujos-Guillot, E., de Wouters, T., Juste, C., Rizkalla, S., Chilloux, J., et al., MICRO-Obes Consortium. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22 (2015), 320–331.
151. Sinha, R., Abu-Ali, G., Vogtmann, E., Fodor, A.A., Ren, B., Amir, A., Schwager, E., Crabtree, J., Ma, S., Abnet, C.C., et al., Microbiome Quality Control Project Consortium. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat. Biotechnol. 35 (2017), 1077–1086.
152. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.-L., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
153. Smits, S.A., Leach, J., Sonnenburg, E.D., Gonzalez, C.G., Lichtman, J.S., Reid, G., Knight, R., Manjurano, A., Changalucha, J., Elias, J.E., et al. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania. Science 357 (2017), 802–806.
154. Sokol, H., Leducq, V., Aschard, H., Pham, H.-P., Jegou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion-Larmurier, I., et al. Fungal microbiota dysbiosis in IBD. Gut 66 (2017), 1039–1048.
155. Sommer, F., Anderson, J.M., Bharti, R., Raes, J., Rosenstiel, P., The resilience of the intestinal microbiota influences health and disease. Nat. Rev. Microbiol. 15 (2017), 630–638.
156. Song, S.J., Lauber, C., Costello, E.K., Lozupone, C.A., Humphrey, G., Berg-Lyons, D., Caporaso, J.G., Knights, D., Clemente, J.C., Nakielny, S., et al. Cohabiting family members share microbiota with one another and with their dogs. eLife, 2, 2013, e00458.
157. Song, S.J., Amir, A., Metcalf, J.L., Amato, K.R., Xu, Z.Z., Humphrey, G., Knight, R., Preservation methods differ in fecal microbiome stability, affecting suitability for field studies. mSystems, 1, 2016 e00021–e16.
158. Sonnenburg, J.L., Bäckhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
159. Stämmler, F., Gläsner, J., Hiergeist, A., Holler, E., Weber, D., Oefner, P.J., Gessner, A., Spang, R., Adjusting microbiome profiles for differences in microbial load by spike-in bacteria. Microbiome, 4, 2016, 28.
160. Stein, R.R., Bucci, V., Toussaint, N.C., Buffie, C.G., Rätsch, G., Pamer, E.G., Sander, C., Xavier, J.B., Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput. Biol., 9, 2013, e1003388.
161. Stokholm, J., Blaser, M.J., Thorsen, J., Rasmussen, M.A., Waage, J., Vinding, R.K., Schoos, A.-M.M., Kunøe, A., Fink, N.R., Chawes, B.L., et al. Maturation of the gut microbiome and risk of asthma in childhood. Nat. Commun., 9, 2018, 141.
162. Suez, J., Elinav, E., The path towards microbiome-based metabolite treatment. Nat. Microbiol., 2, 2017, 17075.
163. Sunagawa, S., Mende, D.R., Zeller, G., Izquierdo-Carrasco, F., Berger, S.A., Kultima, J.R., Coelho, L.P., Arumugam, M., Tap, J., Nielsen, H.B., et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. Methods 10 (2013), 1196–1199.
164. Surana, N.K., Kasper, D.L., Moving beyond microbiome-wide associations to causal microbe identification. Nature, 375, 2017, 2369.
165. Suzuki, T.A., Worobey, M., Geographical variation of human gut microbial composition. Biol. Lett., 10, 2014, 20131037.
166. Sze, M.A., Schloss, P.D., Looking for a signal in the noise: revisiting obesity and the microbiome. MBio, 7, 2016 e01018–e16.
167. Tamburini, S., Shen, N., Wu, H.C., Clemente, J.C., The microbiome in early life: implications for health outcomes. Nat. Med. 22 (2016), 713–722.
168. Thaiss, C.A., Zmora, N., Levy, M., Elinav, E., The microbiome and innate immunity. Nature 535 (2016), 65–74.
169. Ticinesi, A., Milani, C., Lauretani, F., Nouvenne, A., Mancabelli, L., Lugli, G.A., Turroni, F., Duranti, S., Mangifesta, M., Viappiani, A., et al. Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients. Sci. Rep., 7, 2017, 11102.
170. Tigchelaar, E.F., Bonder, M.J., Jankipersadsing, S.A., Fu, J., Wijmenga, C., Zhernakova, A., Gut microbiota composition associated with stool consistency. Gut 65 (2016), 540–542.
171. Tito, R.Y., Cypers, H., Joossens, M., Varkas, G., Van Praet, L., Glorieus, E., Van den Bosch, F., De Vos, M., Raes, J., Elewaut, D., Brief report: dialister as a microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol. 69 (2017), 114–121.
172. Tramontano, M., Andrejew, S., Pruteanu, M., Klünemann, M., Kuhn, M., Galardini, M., Jouhten, P., Zelezniak, A., Zeller, G., Bork, P., et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat. Microbiol., 2018, 10.1038/s41564-018-0123-9.
173. Tremaroli, V., Karlsson, F., Werling, M., Ståhlman, M., Kovatcheva-Datchary, P., Olbers, T., Fändriks, L., le Roux, C.W., Nielsen, J., Bäckhed, F., Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22 (2015), 228–238.
174. Truong, D.T., Tett, A., Pasolli, E., Huttenhower, C., Segata, N., Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 27 (2017), 626–638.
175. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
176. Turpin, W., Espin-Garcia, O., Xu, W., Silverberg, M.S., Kevans, D., Smith, M.I., Guttman, D.S., Griffiths, A., Panaccione, R., Otley, A., et al., GEM Project Research Consortium. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat. Genet. 48 (2016), 1413–1417.
177. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., Visser, C.E., Kuijper, E.J., Bartelsman, J.F.W.M., Tijssen, J.G.P., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
178. Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R.Y., Joossens, M., Raes, J., Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 (2016), 57–62.
179. Vandeputte, D., Falony, G., D'hoe, K., Vieira-Silva, S., Raes, J., Water activity does not shape the microbiota in the human colon. Gut 66 (2017), 1865–1866.
180. Vandeputte, D., Falony, G., Vieira-Silva, S., Wang, J., Sailer, M., Theis, S., Verbeke, K., Raes, J., Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut 66 (2017), 1968–1974.
181. Vandeputte, D., Kathagen, G., D'hoe, K., Vieira-Silva, S., Valles-Colomer, M., Sabino, J., Wang, J., Tito, R.Y., De Commer, L., Darzi, Y., et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551 (2017), 507–511.
182. Vandeputte, D., Tito, R.Y., Vanleeuwen, R., Falony, G., Raes, J., Practical considerations for large-scale gut microbiome studies. FEMS Microbiol. Rev. 41:Supp_1 (2017), S154–S167.
183. Vázquez-Baeza, Y., Callewaert, C., Debelius, J., Hyde, E., Marotz, C., Morton, J.T., Swafford, A., Vrbanac, A., Dorrestein, P.C., Knight, R., Impacts of the human gut microbiome on therapeutics. Annu. Rev. Pharmacol. Toxicol. 58 (2018), 253–270.
184. Vermeire, S., Joossens, M., Verbeke, K., Wang, J., Machiels, K., Sabino, J., Ferrante, M., Van Assche, G., Rutgeerts, P., Raes, J., Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J. Crohn's Colitis 10 (2016), 387–394.
185. Vétizou, M., Pitt, J.M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P.M., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
186. Voigt, A.Y., Costea, P.I., Kultima, J.R., Li, S.S., Zeller, G., Sunagawa, S., Bork, P., Temporal and technical variability of human gut metagenomes. Genome Biol., 16, 2015, 73.
187. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R.S., Bartelsman, J.F.W.M., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.
188. Walsh, C.J., Guinane, C.M., O'Toole, P.W., Cotter, P.D., Beneficial modulation of the gut microbiota. FEBS Lett. 588 (2014), 4120–4130.
189. Walters, W.A., Xu, Z., Knight, R., Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 588 (2014), 4223–4233.
190. Wang, J., Jia, H., Metagenome-wide association studies: fine-mining the microbiome. Nat. Rev. Microbiol. 14 (2016), 508–522.
191. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.-M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
192. Wang, J., Thingholm, L.B., Skiecevičienė, J., Rausch, P., Kummen, M., Hov, J.R., Degenhardt, F., Heinsen, F.-A., Rühlemann, M.C., Szymczak, S., et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat. Genet. 48 (2016), 1396–1406.
193. Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., Wang, B., Systematic review: adverse events of fecal microbiota transplantation. PLoS ONE, 11, 2016, e0161174.
194. Wassenaar, T.M., Insights from 100 years of research with probiotic E. coli. Eur. J. Microbiol. Immunol. (Bp.) 6 (2016), 147–161.
195. Weiss, S., Van Treuren, W., Lozupone, C., Faust, K., Friedman, J., Deng, Y., Xia, L.C., Xu, Z.Z., Ursell, L., Alm, E.J., et al. Correlation detection strategies in microbial data sets vary widely in sensitivity and precision. ISME J. 10 (2016), 1669–1681.
196. Weiss, S., Xu, Z.Z., Peddada, S., Amir, A., Bittinger, K., Gonzalez, A., Lozupone, C., Zaneveld, J.R., Vázquez-Baeza, Y., Birmingham, A., et al. Normalization and microbial differential abundance strategies depend upon data characteristics. Microbiome, 5, 2017, 27.
197. H17 axis and disease. Nature 551 (2017), 585–589.
198. Wlodarska, M., Kostic, A.D., Xavier, R.J., An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17 (2015), 577–591.
199. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
200. Wu, H., Esteve, E., Tremaroli, V., Khan, M.T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L.M., Serino, M., Planas-Fèlix, M., et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23 (2017), 850–858.
201. Xie, H., Guo, R., Zhong, H., Feng, Q., Lan, Z., Qin, B., Ward, K.J., Jackson, M.A., Xia, Y., Chen, X., et al. Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome. Cell Syst. 3 (2016), 572–584.
202. Xu, J., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., Guo, Y., Zhang, C., Zhou, Q., Xue, Z., et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J. 9 (2015), 552–562.
203. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
204. Yutin, N., Makarova, K.S., Gussow, A.B., Krupovic, M., Segall, A., Edwards, R.A., Koonin, E.V., Discovery of an expansive bacteriophage family that includes the most abundant viruses from the human gut. Nat. Microbiol. 3 (2018), 38–46.
205. Zaneveld, J.R., McMinds, R., Vega Thurber, R., Stress and stability: applying the Anna Karenina principle to animal microbiomes. Nat. Microbiol., 2, 2017, 17121.
206. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094.
207. Zeller, G., Tap, J., Voigt, A.Y., Sunagawa, S., Kultima, J.R., Costea, P.I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol., 10, 2014, 766.
208. Zhang, C., Yin, A., Li, H., Wang, R., Wu, G., Shen, J., Zhang, M., Wang, L., Hou, Y., Ouyang, H., et al. Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine 2 (2015), 968–984.
209. Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21 (2015), 895–905.
210. Zhernakova, A., Kurilshikov, A., Bonder, M.J., Tigchelaar, E.F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A.V., Falony, G., Vieira-Silva, S., et al., LifeLines cohort study. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352 (2016), 565–569.
211. Zhou, W., Gay, N., Oh, J., ReprDB and panDB: minimalist databases with maximal microbial representation. Microbiome, 6, 2018, 15.
212. Zhu, W., Winter, M.G., Byndloss, M.X., Spiga, L., Duerkop, B.A., Hughes, E.R., Büttner, L., de Lima Romão, E., Behrendt, C.L., Lopez, C.A., et al. Precision editing of the gut microbiota ameliorates colitis. Nature 553 (2018), 208–211.
213. Zmora, N., Zeevi, D., Korem, T., Segal, E., Elinav, E., Taking it personally: personalized utilization of the human microbiome in health and disease. Cell Host Microbe 19 (2016), 12–20.